Asia accounted for approximately 45% of the global breast cancer cases in 2020, with Mainland China, India, and Japan contributing the majority of cases.

Other relevant content

March 26, 2024 Report

Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024)

...

Download
September 1, 2023 Report

Nasopharyngeal Carcinoma: Global Clinical Trial Landscape

...

Download
August 28, 2023 Report

Gallbladder Cancer: Global Clinical Trial Landscape

...

Download
June 26, 2023 Report

Liver Cancer Global Clinical trial landscape- Focus on Asia Pacific

...

Download
May 26, 2023 Report

Non-Hodgkin Lymphoma Global Clinical trial Landscape- Focus on Asia Pacific

...

Download
August 25, 2019 Case Study

Rescue study and Oncology CRO services. Local know-how gets pivotal breast cancer trial back on…

...

Read More
September 5, 2023 Whitepaper

Rare Disease – Global Clinical Trial Landscape (2018-2022)

...

Download
June 2, 2023 Whitepaper

Oncolytic Virus Therapies– Global Clinical Trial Landscape - Focus On Asia Pacific

...

Download
June 14, 2023 Webinar

Endpoints at ASCO23: How to accelerate development in novel & advanced oncology therapies — from…

What ways are we innovating CAR-T, ADCs, Immunotherapies, and mRNAs as they wind their way through the pipeline and beyond? How…

Watch
May 26, 2023 News

Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development…

...

Read more Notification Icon
June 2-6, 2023 Events

ASCO Annual Meeting (In Person)

Chicago

Read More
Expertise Icon
  Expertise

Oncology CRO services

...

Expertise Icon